{"entity":{"type":"insider","cik":"0001367082","url":"/insider/0001367082","json_url":"/insider/0001367082.json","name":"Miller Robert E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":9,"first":"2009-11-12","last":"2018-03-14","span_basis":"filed_date"},"name_variants":[{"name":"Miller Robert E","source":"filing","n_filings":9,"first_seen":"2009-11-12","last_seen":"2018-03-14"}],"transactions":[{"id":6429888,"accession":"0001683168-18-000672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-18-000672","line_url":"/filing/0001683168-18-000672#line-2","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":4.0996,"price_display":"4.10","price_state":"stated","total_value":4919.52,"total_display":"4,919.52","total_whole":"4,920","shares_owned_after":18868.0,"shares_owned_after_display":"18,868","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-14","scope":"insider"},{"id":6429885,"accession":"0001683168-18-000672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-18-000672","line_url":"/filing/0001683168-18-000672#line-1","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":4836.0,"total_display":"4,836.00","total_whole":"4,836","shares_owned_after":17668.0,"shares_owned_after_display":"17,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"},{"id":6404486,"accession":"0001683168-18-000658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-18-000658","line_url":"/filing/0001683168-18-000658#line-2","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par vlue per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":4836.0,"total_display":"4,836.00","total_whole":"4,836","shares_owned_after":16468.0,"shares_owned_after_display":"16,468","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-13","scope":"insider"},{"id":6404482,"accession":"0001683168-18-000658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-18-000658","line_url":"/filing/0001683168-18-000658#line-1","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par vlue per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":4680.0,"total_display":"4,680.00","total_whole":"4,680","shares_owned_after":15268.0,"shares_owned_after_display":"15,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-09","filed_date":"2018-03-13","scope":"insider"},{"id":4251099,"accession":"0001683168-17-003193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-17-003193","line_url":"/filing/0001683168-17-003193","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1790.0,"shares_display":"1,790","price_per_share":5.022793296089385,"price_display":"5.02","price_state":"stated","total_value":8990.8,"total_display":"8,990.80","total_whole":"8,991","shares_owned_after":14068.0,"shares_owned_after_display":"14,068","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-29","filed_date":"2017-11-30","scope":"insider","n_lines":2},{"id":4958216,"accession":"0001683168-17-003152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-17-003152","line_url":"/filing/0001683168-17-003152","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.0325,"price_display":"5.03","price_state":"stated","total_value":10065.0,"total_display":"10,065.00","total_whole":"10,065","shares_owned_after":11778.0,"shares_owned_after_display":"11,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2017-11-24","scope":"insider","n_lines":2},{"id":5232748,"accession":"0001683168-17-002133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-17-002133","line_url":"/filing/0001683168-17-002133#line-1","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2264.0,"shares_display":"2,264","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":11999.2,"total_display":"11,999.20","total_whole":"11,999","shares_owned_after":10728.0,"shares_owned_after_display":"10,728","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-10","filed_date":"2017-08-14","scope":"insider"},{"id":5129030,"accession":"0001683168-17-000551","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-17-000551","line_url":"/filing/0001683168-17-000551","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":7.023333333333333,"price_display":"7.02","price_state":"stated","total_value":5267.5,"total_display":"5,267.50","total_whole":"5,268","shares_owned_after":8464.0,"shares_owned_after_display":"8,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-13","scope":"insider","n_lines":3},{"id":5167171,"accession":"0001683168-17-000533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-17-000533","line_url":"/filing/0001683168-17-000533","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.93,"price_display":"6.93","price_state":"stated","total_value":6930.0,"total_display":"6,930.00","total_whole":"6,930","shares_owned_after":7714.0,"shares_owned_after_display":"7,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-08","filed_date":"2017-03-09","scope":"insider","n_lines":2},{"id":2140434,"accession":"0001683168-16-000915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-16-000915","line_url":"/filing/0001683168-16-000915#line-1","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":24300.0,"total_display":"24,300.00","total_whole":"24,300","shares_owned_after":6714.0,"shares_owned_after_display":"6,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2016-12-12","scope":"insider"},{"id":5788063,"accession":"0001209191-09-052435","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-09-052435","line_url":"/filing/0001209191-09-052435","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.6499,"price_display":"1.65","price_state":"stated","total_value":6599.6,"total_display":"6,599.60","total_whole":"6,600","shares_owned_after":73000.0,"shares_owned_after_display":"73,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-11","filed_date":"2009-11-12","scope":"insider","n_lines":2},{"id":5788059,"accession":"0001209191-09-052435","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-09-052435","line_url":"/filing/0001209191-09-052435","is_derivative":false,"issuer_cik":"0001367082","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367082","owner_cik":"0001367082","owner_name":"Miller Robert E","owner_display_name":"Miller Robert E","owner_url":"/insider/0001367082","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":1.693261111111111,"price_display":"1.69","price_state":"stated","total_value":15239.35,"total_display":"15,239.35","total_whole":"15,239","shares_owned_after":64000.0,"shares_owned_after_display":"64,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-10","filed_date":"2009-11-12","scope":"insider","n_lines":7}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367083","name":"Sonoma Pharmaceuticals, Inc.","url":"/issuer/0001367083","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2009-11-12","last_seen":"2018-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001367082","retrieved_at":"2026-08-27T07:22:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}